As of Sep 20
| -0.19 / -3.07%|
The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +50.00% increase from the last price of 6.00.
The current consensus among 6 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.